Next Frontiers in Precision Oncology… Meet Laura Agresta, MD

By Administrator at 10 Sep 2020

Precision oncology aims for cures that are more effective and less toxic than conventional therapies by targeting the biological pathways that drive certain cancers. This growing field has long been a focus of Gateway for Cancer Research. Earlier this year, Gateway and Conquer Cancer®, the ASCO Foundation presented the annual Young Investigators Award to Laura Agresta, MD, to advance her precision oncology trial to treat pediatric acute myeloid leukemia.

0 comments posted



    2020 2019 2018 2017 2016 2015
    99 cents of every dollar received directly funds cancer clinical trials


    Current Gateway-funded clinical trials


    Clinical trials funded at leading institutions worldwide


    Funds one patient for one day at a Gateway-funded clinical trial


    Mission Partners